Načítá se...
Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection
The recent discovery of small molecules targeting the cytochrome bc(1):aa(3) in Mycobacterium tuberculosis triggered interest in the terminal respiratory oxidases for antituberculosis drug development. The mycobacterial cytochrome bc(1):aa(3) consists of a menaquinone:cytochrome c reductase (bc(1))...
Uloženo v:
| Vydáno v: | Proc Natl Acad Sci U S A |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
National Academy of Sciences
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5514758/ https://ncbi.nlm.nih.gov/pubmed/28652330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1706139114 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|